Dyne Therapeutics enters underwriting agreement for 18.3M common stock shares
Dyne Therapeutics, Inc. entered an underwriting agreement with Morgan Stanley & Co. LLC and Jefferies LLC to sell 18.3 million shares of common stock, with up to 2.745 million additional shares available for purchase by underwriters.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day